TWD 49.25
(-9.96%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -134.25 Million TWD | -23.89% |
2022 | -108.36 Million TWD | -1021.16% |
2021 | -9.66 Million TWD | 17.83% |
2020 | -11.76 Million TWD | -237.41% |
2019 | -3.48 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -60.01 Million TWD | -0.63% |
2024 Q1 | -59.63 Million TWD | 55.58% |
2023 Q1 | -22.81 Million TWD | 0.0% |
2023 FY | -134.25 Million TWD | -23.89% |
2023 Q4 | -134.25 Million TWD | -304.48% |
2023 Q3 | -33.19 Million TWD | -3.97% |
2023 Q2 | -31.92 Million TWD | -39.93% |
2022 Q4 | - TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -74.254% |
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 49.18% |
Level Biotechnology Inc. | -453.9 Million TWD | 70.423% |
Sagittarius Life Science Corp | -120.57 Million TWD | -11.348% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | 31.643% |
TaiMed Biologics Inc. | 499.84 Million TWD | 126.859% |
GlycoNex Incorporation | -148.56 Million TWD | 9.635% |
VBI | -25.31 Million TWD | -430.305% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 433.413% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 197.288% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 48.872% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 539.048% |
Visgeneer Inc. | 31.28 Million TWD | 529.139% |
Mycenax Biotech Inc. | 207 Million TWD | 164.853% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 80.275% |
Neith Corporation | -150.31 Million TWD | 10.684% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 121.6% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -132.842% |
Enimmune corporation | -314.15 Million TWD | 57.266% |
TaiRx, Inc. | -147.86 Million TWD | 9.209% |
CHO Pharma, Inc. | -203.79 Million TWD | 34.123% |
EirGenix Inc. | -4.58 Billion TWD | 97.074% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -58.385% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 211.07% |
Lin BioScience, Inc. | -3.21 Billion TWD | 95.828% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 57.705% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -577.596% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | 522.057% |
Lukas Biomedical Inc. | 50.75 Million TWD | 364.51% |
RBC Bioscience Corporation | 422.18 Million TWD | 131.799% |
BiOptic Inc. | 12.59 Million TWD | 1166.169% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 85.784% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -32.286% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 18.722% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 142.637% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -108.722% |
NaviFUS Corp. | -123.12 Million TWD | -9.034% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 281.297% |
Sinew Pharma Inc. | -160.34 Million TWD | 16.273% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 44.499% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 60.207% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 67.465% |
AP Biosciences Inc | -196.52 Million TWD | 31.688% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 119.493% |
3D Global Biotech Inc. | -11.43 Million TWD | -1073.839% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 83.819% |
Intech Biopharm Corporation | 1.35 Billion TWD | 109.891% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 67.641% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 35.868% |
TWi Biotechnology, Inc. | -143.86 Million TWD | 6.681% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 59.384% |
TCI GENE Inc. | -689.25 Million TWD | 80.522% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -12.876% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 89.746% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 755.431% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -31.788% |
PharmaEngine, Inc. | -860.8 Million TWD | 84.404% |
Savior Lifetec Corporation | -812.54 Million TWD | 83.478% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 55.245% |
OBI Pharma, Inc. | -398.22 Million TWD | 66.287% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 63.261% |
Acepodia, Inc. | -6.02 Billion TWD | 97.77% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 96.053% |